Fumarate Hydratase Deficiency in Renal Cancer Induces Glycolytic Addiction and Hypoxia-Inducible Transcription Factor 1α Stabilization by Glucose-Dependent Generation of Reactive Oxygen Species

On the origin of cancer cells

Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425

Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation

Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535

HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing

Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735

HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia

Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333

A conserved family of prolyl-4-hydroxylases that modify HIF

Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549

Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase

Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108

Mutations of the VHL tumour suppressor gene in renal carcinoma

Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730

Hypoxia, HIF1 and glucose metabolism in the solid tumour

Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer

The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635

Molecular markers of paragangliomas/pheochromocytomas

Zhikrivetskaya, S. O., Snezhkina, A. V., Zaretsky, A. R., Alekseev, B. Y., Pokrovsky, A. V., Golovyuk, A. L., Melnikova, N. V., Stepanov, O. A., Kalinin, D. V., Moskalev, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15201 · Cited by 45

Metabolic Alterations in Cancer Cells and the Emerging Role of Oncometabolites as Drivers of Neoplastic Change

Zhou, Z., Ibekwe, E., & Chornenkyy, Y. (2018) · Antioxidants · doi:10.3390/antiox7010016 · Cited by 44

Clinical and biochemical heterogeneity associated with fumarase deficiency

Ottolenghi, C., Hubert, L., Allanore, Y., Brassier, A., Altuzarra, C., Mellot‐Draznieks, C., Bekri, S., Goldenberg, A., Veyrieres, S., Boddaert, N., et al. (2011) · Human Mutation · doi:10.1002/humu.21534 · Cited by 43

Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis

Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2020) · doi:10.1101/2020.06.27.175679 · Cited by 414

The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma

Kang, W., Zhang, M., Wang, Q., Gu, D., Huang, Z., Wang, H., Xiang, Y., Xia, Q., Cui, Z., & Jin, X. (2020) · BioMed Research International · doi:10.1155/2020/1932948 · Cited by 37

Fumarate hydratase inactivation in renal tumors: HIF1 alpha, NRF2, and "cryptic targets" of transcription factors

Ooi, A., & Furge, K. A. (2012) · 癌症：英文版 · doi:10.5732/cjc.012.10102 · Cited by 38

The TGF-β/HDAC7 axis suppresses TCA cycle metabolism in renal cancer

Nam, H., Kundu, A., Karki, S., Brinkley, G. J., Chandrashekar, D. S., Kirkman, R. L., Liu, J., Liberti, M. V., Locasale, J. W., Mitchell, T., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.148438 · Cited by 36

Uncommon hereditary gynaecological tumour syndromes: pathological features in tumours that may predict risk for a germline mutation

Garg, K., Karnezis, A. N., & Rabban, J. T. (2018) · Pathology · doi:10.1016/j.pathol.2017.10.009 · Cited by 35

Warburg Effect’s Manifestation in Aggressive Pheochromocytomas and Paragangliomas: Insights from a Mouse Cell Model Applied to Human Tumor Tissue

Fliedner, S. M. J., Kaludercic, N., Jiang, X.-S., Hansíková, H., Hájková, Z., Sládková, J., Limpuangthip, A., Backlund, P. S., WESLEY, R. A., Martiniova, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040949 · Cited by 34

Metabolomics bridging proteomics along metabolites/oncometabolites and protein modifications: Paving the way toward integrative multiomics

Nalbantoğlu, S., & Karadağ, A. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.114031 · Cited by 34

Cells Lacking the Fumarase Tumor Suppressor Are Protected from Apoptosis through a Hypoxia-Inducible Factor-Independent, AMPK-Dependent Mechanism

Bardella, C., Olivero, M., Lorenzato, A., Geuna, M., Adam, J., O'Flaherty, L., Rustin, P., Tomlinson, I., Pollard, P. J., & Di Renzo, M. F. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06160-11 · Cited by 33

Synthetic lethal approaches for assessing combinatorial efficacy of chemotherapeutic drugs

Jackson, R. A., & Chen, E. S. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.01.014 · Cited by 33

Loss of SDHB Elevates Catecholamine Synthesis and Secretion Depending on ROS Production and HIF Stabilization

Saito, Y., Ishii, K., Aita, Y., Ikeda, T., Kawakami, Y., Shimano, H., Hara, H., & Takekoshi, K. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1738-3 · Cited by 35

Hereditary leiomyomatosis and renal cell carcinoma syndrome associated uterine smooth muscle tumors: Bridging morphology and clinical screening

Garg, K., & Rabban, J. T. (2020) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22905 · Cited by 31

Gene of the month: FH

Zyla, R. E., & Hodgson, A. (2021) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2021-207830 · Cited by 31

Role of HIF in fish inflammation

Shi, X., Gao, F., Zhao, X., Pei, C., Zhu, L., Zhang, J., Li, C., Li, L., & Kong, X. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.109222 · Cited by 28

Pheochromocytoma: Gasping for Air

Jochmanová, I., Zhuang, Z., & Pacák, K. (2015) · Hormones and Cancer · doi:10.1007/s12672-015-0231-4 · Cited by 30

Increasing reactive oxygen species as a therapeutic approach to treat hereditary leiomyomatosis and renal cell carcinoma

Sourbier, C., Romero, V. V., Giubellino, A., Yang, Y., Sudarshan, S., Neckers, L., & Linehan, W. M. (2010) · Cell Cycle · doi:10.4161/cc.9.20.13458 · Cited by 29

Endothelin-converting enzyme is a plausible target gene for hypoxia-inducible factor

Khamaisi, M., Toukan, H., Axelrod, J. H., Rosenberger, C., Skarzinski, G., Shina, A., Meidan, R., Koesters, R., Rosen, S., Walkinshaw, G., et al. (2014) · Kidney International · doi:10.1038/ki.2014.362 · Cited by 26

Kidney Cancer Pathology in the New Context of Targeted Therapy

Allory, Y., Culine, S., & TAILLE, A. D. L. (2011) · Pathobiology · doi:10.1159/000315543 · Cited by 25

Up-regulation of mitochondrial antioxidation signals in ovarian cancer cells with aggressive biologic behavior

Wang, Y., Li, D., Cui, H., Shen, D., Wang, Y., Chang, X.-H., Fu, T., Ye, X., & Yao, Y. (2011) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1000192 · Cited by 26

Hereditary Renal Tumor Syndromes: Update on Diagnosis and Management

Gaur, S., Türkbey, B., & Choyke, P. L. (2016) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2016.10.002 · Cited by 24

Constraint based modeling of metabolism allows finding metabolic cancer hallmarks and identifying personalized therapeutic windows

Bordel, S. (2018) · Oncotarget · doi:10.18632/oncotarget.24805 · Cited by 23

Pathologic Oxidation of PTPN12 Underlies ABL1 Phosphorylation in Hereditary Leiomyomatosis and Renal Cell Carcinoma

Xu, Y., Taylor, P. P., Andrade, J., Ueberheide, B. M., Shuch, B. M., Glazer, P. M., Bindra, R. S., Moran, M. F., Linehan, W. M., & Neel, B. G. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0901 · Cited by 24

Genetically Modeled Mice with Mutations in Mitochondrial Metabolic Enzymes for the Study of Cancer

Piruat, J. I., & Millán‐Uclés, Á. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00200 · Cited by 21

Epigenetic regulation by endogenous metabolite pharmacology

Kulkarni, R. A., Montgomery, D. C., & Meier, J. L. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.02.002 · Cited by 24

A role for fumarate hydratase in mediating oxidative effects of galectin-3 in human cardiac fibroblasts

Ibarrola, J., Sádaba, R., García-Peña, A., Arrieta, V., Martínez‐Martínez, E., Álvarez, V., Fernández‐Celis, A., Gainza, A., Santamaría, E., Fernández‐Irigoyen, J., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.12.103 · Cited by 22

Fumarate hydratase as a therapeutic target in renal cancer

Kancherla, P., Daneshvar, M., Sager, R., Mollapour, M., & Bratslavsky, G. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1804862 · Cited by 20

Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup

Liu, Y. J., Houldsworth, J., Emmadi, R., Dyer, L. M., & Wolff, D. J. (2020) · Cancer Genetics · doi:10.1016/j.cancergen.2020.04.004 · Cited by 19

High Ambient Temperature Aggravates Experimental Autoimmune Uveitis Symptoms

Pan, S., Tan, H., Chang, R., Wang, Q., Zhu, Y., Chen, L., Li, H., Su, G., Zhou, C., Cao, Q., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.629306 · Cited by 19

Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio

van Gisbergen, M. W., Zwilling, E., & Dubois, L. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.653621 · Cited by 20

Mitigating Lactate-Associated Immunosuppression against Intracellular Bacteria Using Thermoresponsive Nanoparticles for Septic Arthritis Therapy

Xiao, S., Yi, J., Zhang, Y., Su, M., & Tang, R. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c00221 · Cited by 18

Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genes

Malayil, R., Chhichholiya, Y., Vasudeva, K., Singh, H. V., Singh, T., Singh, S., & Munshi, A. (2023) · Medical Oncology · doi:10.1007/s12032-023-02037-2 · Cited by 19

In vitro ischemia suppresses hypoxic induction of hypoxia‐inducible factor‐1α by inhibition of synthesis and not enhanced degradation

Karuppagounder, S. S., Basso, M., Sleiman, S. F., Ma, T. C., Speer, R. E., Smirnova, N. A., Gazaryan, I. G., & Ratan, R. R. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23204 · Cited by 17

Renal Carcinogenesis, Tumor Heterogeneity, and Reactive Oxygen Species: Tactics Evolved

Shanmugasundaram, K., & Block, K. L. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6569 · Cited by 19

The molecular characterization and therapeutic strategies of papillary renal cell carcinoma

Chen, Q., Liang Cheng, C., & Li, Q. (2018) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2019.1548939 · Cited by 17

Intracellular Succinylation of 8-Chloroadenosine and Its Effect on Fumarate Levels

Dennison, J. B., Ayres, M., Kaluarachchi, K. K., Plunkett, W. K., & Gandhi, V. V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.085803 · Cited by 17

Stabilization but No Functional Influence of HIF-1α Expression in the Intestinal Epithelium during Salmonella Typhimurium Infection

Robrahn, L., Dupont, A., Jumpertz, S., Zhang, K., Holland, C. H., Guillaume, J., Rappold, S., Roth, J., Cerovic, V., Sáez-Rodríguez, J., et al. (2022) · Infection and Immunity · doi:10.1128/iai.00222-21 · Cited by 16

A study exploring critical pathways in clear cell renal cell carcinoma

Zeng, Z., Que, T., Zhang, J., & Hu, Y. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1392 · Cited by 16

Non-clear cell advanced kidney cancer

Sánchez, P., Calvo, E., & Durán, I. (2010) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000390767.85658.83 · Cited by 17

Synthetically Lethal Interactions of Heme Oxygenase-1 and Fumarate Hydratase Genes

Podkalicka, P., Mucha, O., Kruczek, S., Biela, A., Andrysiak, K., Stępniewski, J., Mikulski, M., Gałȩzowski, M., Sitarz, K. S., Brzózka, K. D., et al. (2020) · Biomolecules · doi:10.3390/biom10010143 · Cited by 17

Chemical Basis for the Selectivity of the von Hippel Lindau Tumor Suppressor pVHL for Prolyl-Hydroxylated HIF-1α

Illingworth, C. J. R., Loenarz, C., Schofield, C. J., & Domene, C. (2010) · Biochemistry · doi:10.1021/bi100358t · Cited by 16

Novel Oxidatively Activated Agents Modify DNA and Are Enhanced by Ercc1 Silencing

Jones, A. R., Bell‐Horwath, T. R., Li, G., Rollmann, S. M., & Merino, E. J. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300337j · Cited by 15

Seeing the smoking gun: a sensitive and specific method to visualize loss of the tumour suppressor, fumarate hydratase, in human tissues

Maxwell, P. H. (2011) · The Journal of Pathology · doi:10.1002/path.2950 · Cited by 15

Integrative Gene Expression Profiling Reveals G6PD-Mediated Resistance to RNA-Directed Nucleoside Analogues in B-Cell Neoplasms

McBrayer, S. K., Yarrington, M. E., Qian, J., Feng, G., Shanmugam, M., Gandhi, V. V., Krett, N. L., & Rosen, S. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041455 · Cited by 15

Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82

Najera, S. S., Ricketts, C. J., Schmidt, L. S., Medina, J. I., Saito, K., Ileva, L. V., Brender, J., James, A. E., Peer, C. J., Gouker, B. A., et al. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-0225 · Cited by 14

HIF-1-mediated expression of Foxo1 serves an important role in the proliferation and apoptosis of osteoblasts derived from children's iliac cancellous bone

Xu, G. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8675 · Cited by 13

Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesis

Costa, B., Dettori, D., Lorenzato, A., Bardella, C., Coltella, N., Martino, C., Cammarata, C., Carmeliet, P., Olivero, M., & Renzo, M. F. D. (2010) · The FASEB Journal · doi:10.1096/fj.09-146928 · Cited by 13

Photoinducible Oncometabolite Detection

Kulkarni, R. A., Briney, C. A., Crooks, D. R., Bergholtz, S. E., Mushti, C., Lockett, S., Lane, A. N., Fan, T. W. ‐., Swenson, R. E., Linehan, W. M., et al. (2018) · ChemBioChem · doi:10.1002/cbic.201800651 · Cited by 12

Direct and quantitative analysis of altered metabolic flux distributions and cellular ATP production pathway in fumarate hydratase-diminished cells

Noguchi, S., Ishikawa, H., Wakita, K., Matsuda, F., & Shimizu, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-70000-6 · Cited by 12

Mitochondrial Tumor Suppressors—The Energetic Enemies of Tumor Progression

Jakoubě, P., Cutano, V., González-Morena, J. M., & Keckesova, Z. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0518 · Cited by 13

Therapeutic Strategies for Hereditary Kidney Cancer

Sidana, A., & Srinivasan, R. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0537-6 · Cited by 12

Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc

Sourbier, C., Ricketts, C. J., Liao, P., Matsumoto, S., Wei, D., Lang, M., Railkar, R. S., Yang, Y., Wei, M.-H., Agarwal, P. K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-55003-2 · Cited by 13

Genomic profile analysis of leiomyomas with bizarre nuclei and fumarate hydratase deficient leiomyomas: Strengths, weaknesses, and limitations of array‐CGH interpretation

Fontanges, Q., Dubos, P., Lesluyes, T., Laizet, Y., Velasco, V., Meléndez, B., D’Haene, N., Oliva, E., Young, R. H., Mayeur, L., et al. (2024) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23229 · Cited by 11

The pathological and molecular genetic landscape of the hereditary renal cancer predisposition syndromes

Al‐Obaidy, K. I., Alruwaii, Z. I., Williamson, S. R., & Liang Cheng, C. (2022) · Histopathology · doi:10.1111/his.14641 · Cited by 11

Druggable Biomarkers Altered in Clear Cell Renal Cell Carcinoma: Strategy for the Development of Mechanism-Based Combination Therapy

Rustum, Y. M., Reis, R. J., & Rustum, T. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24020902 · Cited by 11

Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Role in Cystogenesis and Novel Therapeutic Approaches

Gao, J., & Yu, X.-Y. (2025) · Biomedicines · doi:10.3390/biomedicines13071596 · Cited by 10

Review: Warburg effect and renal cancer caused by errs in fumarate hydratase encoding gene.

Qureshi, A. S., & Ali, S. (2019) · PubMed · Cited by 10

Molecular signature of renal cell carcinoma by means of a multiplatform metabolomics analysis

Kordalewska, M., Wawrzyniak, R., Jacyna, J., Godzień, J., López‐Gonzálvez, Á., Raczak‐Gutknecht, J., Markuszewski, M., Gutknecht, P. G., Matuszewski, M., Siebert, J., et al. (2022) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2022.101318 · Cited by 10

Kidney cancer: from genes to therapy

Webster, B. R., Rompré‐Brodeur, A., Daneshvar, M., Pahwa, R., & Srinivasan, R. (2021) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2021.100773 · Cited by 9

Knowledge of hereditary renal cancer syndromes

García-Donás, J., Hernando, S., Romero-Laorden, N., & Jara, C. (2010) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000390768.93282.65 · Cited by 8

Research Translation and Personalized Medicine

Brugarolas, J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2400-0_8 · Cited by 7

Bioinformatics analysis and expression study of fumarate hydratase in lung cancer

Ming, Z., Jiang, M., Li, W., Fan, N., Deng, W., Zhong, Y., Zhang, Y., Zhang, Q., & Yang, S. (2014) · Thoracic Cancer · doi:10.1111/1759-7714.12127 · Cited by 7

Conditional Covalent Lethality Driven by Oncometabolite Accumulation

Perez, M., Nance, K. D., Bak, D. W., Gamage, S. T., Najera, S. S., Conte, A. N., Linehan, W. M., Weerapana, E., & Meier, J. L. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00384 · Cited by 6

Cancer of the Kidney

McNamara, M. A., Zhang, T., Harrison, M. R., & George, D. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00079-7 · Cited by 7

Metabolism and Oxidative Stress Response Pathways in Kidney Cancer: A Tale of Chance and Necessity

Sourbier, C., Srinivasan, R., & Linehan, W. M. (2015) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2015.35.220 · Cited by 6

Oxidative Stress and Redox-Signaling in Renal Cell Cancer

Block, K. L. (2012) · InTech eBooks · doi:10.5772/26747 · Cited by 6

Uterine fibroids and current clinical challenges

Salama, S., & Kilic, G. S. (2013) · Journal of the Turkish-German Gynecological Association · doi:10.5152/jtgga.2013.09 · Cited by 6

Tuning the Fire: Context-Dependent Mitochondrial ROS Signaling, Mitohormesis, and Redox-Modulating Interventions

Charidemou, E., Andreou, E. P., & Papaneophytou, C. P. (2026) · Biomolecules · doi:10.3390/biom16060867 · Cited by 7

Hydrophilic interaction liquid chromatography coupled with MS / MS to detect and quantify dicarboxyethyl glutathione, a metabolic biomarker of the fumarate hydratase deficient cancer cell

Nguyen, H. P., Chandel, N. S., DeBerardinis, R. J., & Schug, K. A. (2013) · Journal of Separation Science · doi:10.1002/jssc.201300602 · Cited by 5

Modeling dioxygenase enzyme kinetics in familial paraganglioma

Peters, J. P., Her, Y. F., & Maher, L. J. (2015) · Biology Open · doi:10.1242/bio.013623 · Cited by 4

Pseudohypoxia, Mitochondrial Mutations, the Warburg Effect, and Cancer.

Sanders, E. (2012) · Cited by 4

Activated Thiol Sepharose‐based proteomic approach to quantify reversible protein oxidation

Xu, Y., Andrade, J., Ueberheide, B. M., & Neel, B. G. (2019) · The FASEB Journal · doi:10.1096/fj.201900693r · Cited by 4

Association Between Iron and Cholesterol in Neuroblastomas

LEE, S. Y., Slagle‐Webb, B., Schengrund, C., Zhu, J., & Connor, J. R. (2021) · Anticancer Research · doi:10.21873/anticanres.15060 · Cited by 4

Örökletes vesetumor-szindrómák.

Sánta, F., Semjén, D., & Kuthi, L. (2023) · Orvosi Hetilap · doi:10.1556/650.2023.32729 · Cited by 4

Thinned young apple powder prevents obesity-induced neuronal apoptosis via improving mitochondrial function of cerebral cortex in mice

Fang, J., Jiang, P., Wang, X., Qi, Z., He, X., Chen, L., Guo, Y., Xiao-yun, X., Liu, R., & Li, D. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109588 · Cited by 5

The Genetic Basis of Kidney Cancer and Implications for Targeted Therapies

Schmidt, L. S., Srinivasan, R., & Linehan, W. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2400-0_1 · Cited by 4

Gastric Leiomyoma and Hyperplastic Polyposis Coli in a Patient with Multiple Cutaneous and Uterine Leiomyomatosis

Serra, D., Amaro, P., Gonçalo, M., Silva, M., Ferrando, B., Pasini, B., & Figueiredo, A. (2012) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/120347541201600315 · Cited by 4

Metabolic Derangements in Succinate Dehydrogenase B–Mutated Renal-Cell Carcinomas: More Than Meets the Eye?

Msaouel, P., Malouf, G. G., & Tannir, N. M. (2017) · JCO Precision Oncology · doi:10.1200/po.17.00037 · Cited by 4

TGF-β signaling suppresses TCA cycle metabolism in renal cancerPreprint

Nam, H., Kundu, A., Karki, S., Brinkley, G. J., Chandrashekar, D. S., Kirkman, R. L., Liu, J., Liberti, M. V., Locasale, J. W., Mitchell, T., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.19.429599 · Cited by 3

Hereditary leiomyomatosis and renal cell cancer syndrome – case report and review of the literature

Popa, L. G., Lutuc, R., Mihai, M. M., Salem, I. A., Negoita, S. I., Giurcăneanu, C., & Fica, S. V. (2020) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.61.2.29 · Cited by 3

Metabolic Pathways of Eukaryotes and Connection to Cell Mechanics

Mierke, C. T. (2020) · Biological and medical physics, biomedical engineering · doi:10.1007/978-3-030-58532-7_17 · Cited by 2

Hereditary Renal Cell Carcinoma

Baba, M., Schmidt, L. S., & Linehan, W. M. (2017) · Springer eBooks · doi:10.1007/978-4-431-55531-5_2 · Cited by 4

Cancer of the Kidney

Пили, Р., KAUFFMAN, E. C., & Rodríguez, R. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00082-5 · Cited by 3

Intratumoral Heterogeneity and Metabolic Cross-Feeding in a Three-Dimensional Breast Cancer Culture: An In Silico Perspective

Arellano-Villavicencio, J. E., Vázquez-Jiménez, A., Vázquez-Jiménez, A., Oropeza-Valdéz, J., Padrón-Manrique, C., Prado-Garcı́a, H., & Tovar, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010894 · Cited by 3

Carcinogenesis trajectories

Wang, R., & Yan, Z. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1671115 · Cited by 2

Molecular Pathogenesis of Renal Cell Carcinoma: A Review

Gomy, I., & Silva, W. A. (2012) · InTech eBooks · doi:10.5772/27950 · Cited by 2

A Case of Reed Syndrome with a Novel Mutation in the Fumarate Hydratase Gene

Laufer, C. B., Green, L. B., & Whittemore, D. E. (2013) · Case Reports in Medicine · doi:10.1155/2013/926896 · Cited by 2

Clinical features of renal cell carcinoma (RCC) found in 110 nephrectomized Japanese, of which 24 (22%) RCC cases showed 31 double or triple cancers

Nakatsuji, T. (2012) · Comparative Clinical Pathology · doi:10.1007/s00580-012-1418-5 · Cited by 1

Molecular Biology and Genetics of Renal Cell Carcinoma

Ghafouri, S. N., Johnson, D. C., Kelly, K., Pantuck, A. J., & Drakaki, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-24378-4_2 · Cited by 1

Bilateral, multicystic fumarate hydratase-deficient renal cell carcinoma in patient with hereditary leiomyomatosis & renal cell carcinoma syndrome: A case report and review of the literature

Rubrecht, A., Aldrink, J. H., Warren, P. S., Mathew, M. T., Tsuchiya, K. D., Moulas, N., Prasad, V. K., & Shah, N. (2025) · Diagnostic Pathology · doi:10.1186/s13000-025-01706-2 · Cited by 1

Revealing the Angiogenic Signature of FH-Deficient Breast Cancer: Genomic Profiling and Clinical Implications

Sinberger, L. A., Keren-Khadmy, N., Goldberg, A., Peretz‐Yablonski, T., Sonnenblick, A., & Salmon‐Divon, M. (2025) · Cancers · doi:10.3390/cancers17182942 · Cited by 1

The application of metabolic network analysis in understanding and targeting metabolism for drug discovery

Liu, J. (2010) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1

Elucidation of Cancer Drivers Through Comparative Omic Data Analyses

Xu, Y., Cui, J., & Puett, D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1381-7_5 · Cited by 1

A Nexus model of cellular transition in cancer

Yadav, M., Chatterjee, P., Tolani, S., Kulkarni, J. L., Mulye, M., Chauhan, N., Sakhi, A., & Gorey, S. (2018) · Biological Research · doi:10.1186/s40659-018-0173-8 · Cited by 1

HIF Biology in RCC: Implications for Signaling, Disease Progression, and Treatment

Rathmell, W. K. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2400-0_3 · Cited by 1

Pathological Oxidation of PTPN12 Underlies ABL1 Phosphorylation in HLRCCPreprint

Xu, Y., Taylor, P. P., Andrade, J., Ueberheide, B. M., Shuch, B. M., Glazer, P. M., Bindra, R. S., Moran, M. F., Linehan, W. M., & Neel, B. G. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/296194 · Cited by 1

Inhibition of haao-1 enhances oxidative stress response by activating hormetic redox signaling in C. elegansPreprint

Castro-Portuguez, R., Raymond, K. M., Thullen, E., Hendrickson, A. M., Freitas, S., Hull, B., Meyers, J., Thorns, N., Gardea, E. A., Dang, H. T. L., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.16.528568 · Cited by 1

Molecular Biology and Genetics

Klomp, J. A., Dykema, K. J., Teh, B. T., & Furge, K. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7236-0_2

Biomarkers for Prognosis and Molecularly Targeted Therapy in Renal Cell Carcinoma

Schmidt, L. S. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-615-9_11

Fumarate Hydratase Deficiency and Cancer: Activation of Hypoxia Signaling?

Ratcliffe, P. J. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.03.015 · Cited by 50

HIF and fumarate hydratase in renal cancer

Sudarshan, S., Linehan, W. M., & Neckers, L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603547 · Cited by 70

Reduced Expression of Fumarate Hydratase in Clear Cell Renal Cancer Mediates HIF-2α Accumulation and Promotes Migration and Invasion

Sudarshan, S., Shanmugasundaram, K., Naylor, S. L., Lin, S., Livi, C. B., O’Neill, C. F., Parekh, D. J., Yeh, I., Sun, L., & Block, K. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021037 · Cited by 53

Neckers L: HIF and fumarate hydratase in renal cancer

Sudarshan, S., Wm, L., & Neckers, L. (2013)

HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability

Isaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.017 · Cited by 958